Liriye Kurtovic

Commercial Road
Melbourne, VIC 3004, Australia

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 25 publications

Relationship between antibody avidity, Fc-mediated functional activity and longevity of malaria vaccine responses in clinical trials.

Relationship between antibody avidity, Fc-mediated functional activity and longevity of malaria vaccine responses in clinical trials.

Journal: Frontiers in immunology
Published: February 11, 2026

Antibody fine specificity correlates with protection from malaria for the RTS,S vaccine in young African children: A post hoc analysis of a phase IIb randomised controlled trial.

Antibody fine specificity correlates with protection from malaria for the RTS,S vaccine in young African children: A post hoc analysis of a phase IIb randomised controlled trial.

Journal: PLoS medicine
Published: December 11, 2025

Declining Antibody Affinity Over Time After Human Vaccination With a Plasmodium falciparum Merozoite Vaccine Candidate.

Declining Antibody Affinity Over Time After Human Vaccination With a Plasmodium falciparum Merozoite Vaccine Candidate.

Journal: The Journal of infectious diseases
Published: February 23, 2024

Induction of Fc-dependent functional antibodies against different variants of SARS-CoV-2 varies by vaccine type and prior infection.

Induction of Fc-dependent functional antibodies against different variants of SARS-CoV-2 varies by vaccine type and prior infection.

Journal: Communications medicine
Published: December 12, 2023

Antibody mechanisms of protection against malaria in RTS,S-vaccinated children: a post-hoc serological analysis of phase 2 trial.

Antibody mechanisms of protection against malaria in RTS,S-vaccinated children: a post-hoc serological analysis of phase 2 trial.

Journal: The Lancet. Microbe
Published: August 24, 2023

A Diversity Covering (DiCo) Plasmodium vivax apical membrane antigen-1 vaccine adjuvanted with RFASE/RSL10 yields high levels of growth-inhibitory antibodies.

A Diversity Covering (DiCo) Plasmodium vivax apical membrane antigen-1 vaccine adjuvanted with RFASE/RSL10 yields high levels of growth-inhibitory antibodies.

Journal: Vaccine
Published: July 11, 2023

Corrigendum: Fc engineered ACE2-Fc is a potent multifunctional agent targeting SARS-CoV2.

Corrigendum: Fc engineered ACE2-Fc is a potent multifunctional agent targeting SARS-CoV2.

Journal: Frontiers in immunology
Published: December 13, 2022

The RTS,S malaria vaccine: Current impact and foundation for the future.

The RTS,S malaria vaccine: Current impact and foundation for the future.

Journal: Science translational medicine
Published: November 16, 2022

Fc engineered ACE2-Fc is a potent multifunctional agent targeting SARS-CoV2.

Fc engineered ACE2-Fc is a potent multifunctional agent targeting SARS-CoV2.

Journal: Frontiers in immunology
Published: March 04, 2022

Induction, decay, and determinants of functional antibodies following vaccination with the RTS,S malaria vaccine in young children.

Induction, decay, and determinants of functional antibodies following vaccination with the RTS,S malaria vaccine in young children.

Journal: BMC medicine
Published: December 22, 2021

Multi-functional antibody profiling for malaria vaccine development and evaluation.

Multi-functional antibody profiling for malaria vaccine development and evaluation.

Journal: Expert review of vaccines
Published: September 17, 2021

Antibody Targets and Properties for Complement-Fixation Against the Circumsporozoite Protein in Malaria Immunity.

Antibody Targets and Properties for Complement-Fixation Against the Circumsporozoite Protein in Malaria Immunity.

Journal: Frontiers in immunology
Published: September 15, 2021
Showing 1-12 of 25

Last Updated: 09/26/2026